SCHEMBL23806754

SCHEMBL23806754

N[C@@H](Cc1c[nH]cn1)C(=O)NBC1CCCCCCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23945565 1.00 — —
SCHEMBL27756045 0.81 SOS1 (0.38) —
SCHEMBL27776884 0.80 SOS1 (0.39) —
SCHEMBL19327375 0.78 SOS1 (0.36) —
SCHEMBL14065661 0.77 SMN1; SMN2 (0.33) —
SCHEMBL24270549 0.77 SMN1; SMN2 (0.33) —
SCHEMBL6957264 0.76 CSK (0.32) —
SCHEMBL30799721 0.76 LTA4H (0.47) —
Histidine SCHEMBL27762881 0.76 TPH1 (0.38) —
SCHEMBL2735529 0.75 TAS1R3 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11117889-B1 IRAK degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2021-09-14 — — US disclosed
Send feedback